USPTO Director: Invalidity Judgment by District Court Does Not Foreclose Inter Partes Review

June 5, 2023

Reading Time : 2 min

In a sua sponte review, USPTO Director Kathy Vidal continued her refinement of the PTAB’s “discretionary denial” practice. Specifically, the Director vacated the Board’s decision to deny institution in Volvo Penta of the Americas, LLC v. Brunswick Corp. (IPR2022-01424). In doing so, the Director clarified the PTAB’s statutory authority to institute an IPR and affirmed that the discretionary denial factors set out in Apple Inc. v. Fintiv, Inc. also apply when an invalidated patent is still on appeal.

In Volvo Penta, an inter partes review petition was filed while the same patent was asserted in a co-pending district court lawsuit. After the petition was filed, the district court held that the sole asserted patent claim was invalid under 35 U.S.C. § 101 and dismissed the case.

While the district court’s decision was on appeal, the Board issued a decision denying IPR institution. The Board gave two reasons for its denial. First, the Board concluded that it did not have statutory authority to institute an IPR on a patent claim held invalid by a district court. In support of its reasoning, the Board pointed to the Federal Circuit’s 2020 decision in Uniloc 2017 LLC v. Hulu, LLC, which explained that the Board’s authority to institute under 35 U.S.C. § 311(b) “is confined to the review of existing patent claims.” According to the Board, the invalidity judgment means that the invalidated claim was no longer an “existing” patent claim subject to IPR. The Board further relied on Federal Circuit case law holding that the pendency of an appeal does not affect the binding nature of the district court’s judgment.

Second, the Board side-stepped applying the Fintiv discretionary denial factors, reasoning that they are relevant only when there is a co-pending district court litigation. Because judgment had already been entered in the district court litigation, it was no longer co-pending, and the factors—including the time to trial and the likelihood of a stay—no longer applied. Accordingly, the Board did not consider the Fintiv factors. Instead, the Board determined that instituting an IPR would increase the risk of wasting resources and reaching inconsistent decisions, and denied institution.

Director Vidal vacated the Board’s decision, finding both of the Board’s reasons flawed. According to the Director, the Board applied irrelevant collateral estoppel rules that have no bearing on the PTAB’s statutory authority to institute under § 311(b). The invalidated claim remains in force until any appeals are resolved, and so the Board retains the authority to institute under § 311(b) despite the district court judgment. As the Director explained, this is fully consistent with the Patent Office’s other policies, including that it does not issue a certificate of cancellation in reissues, IPRs, or ex parte reexaminations until after all appeals have been exhausted.

Similarly, the Director held that because the district court’s invalidity decision was “non-final,” the patent was still subject to judicial review and the Fintiv factors still applied. Thus, the case was remanded to the Board with instructions to evaluate the case under Fintiv, and to consider whether to terminate any instituted proceedings if the invalidity determination is upheld on appeal.

Practice Tip: Patent Owners and Petitioners should be aware that a district court’s early-case invalidation of an asserted patent claim does not necessarily bar institution of an IPR so long as the appeal is still pending. Under these circumstances, the parties should consider thoroughly addressing the Fintiv factors before the PTAB.

Volvo Penta of the Americas, LLC v. Brunswick Corp., IPR2022-01424, Paper 12 (P.T.A.B. Feb. 16, 2023).

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.